Report Feature
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global DNA and gene chip (microarray) market report, please download the report brochure.
The study includes trends and forecast for the global DNA and gene chip (microarray) market by product, type, application, end use, and region as follows:
- Consumables
- Instrumentation
By Type [Value ($ Million) shipment analysis for 2014 – 2025]:
- Oligonucleotide Based Chips
- cDNA (Complementary Deoxyribonucleic Acid) Chips
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
- Gene Expression
- Genomics
- Cancer Diagnosis & Treatment
- Environmental Control
- Agricultural Biology
- Microbial Genotyping
- Toxic Genomics
- Drug Discovery
By End Use [Value ($ Million) shipment analysis for 2014 – 2025]:
- Academic & Government Research Institutes
- Hospitals & Diagnostic Centers
- Biotechnology & Pharmaceutical Companies
- Others
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Germany
- France
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
- Brazil
Some of the DNA and dene chip (microarray) companies profiled in this report include Affymetrix, Illumina, Agilent Technologies, Roche, Sequenom, Applied Microarrays, Oxford Gene Technology, PerkinElmer, Eurofins Discovery, and NGK Insulators.
Lucintel forecasts that consumables will remain the largest product segment over the forecast period, as reagents and other ancillary components are easily available as compared to instruments which are required for implementing a microarray procedure.
Within this market, academic and government research institutes will remain the largest end use segment over the forecast period due to increasing research activities related to gene expression analysis.
North America will remain the largest region over the forecast period due to rising investments in R&D activities related to genomics, advanced healthcare infrastructure, and presence of major players in the region.
|
Features of the Global DNA and Gene Chip (Microarray) Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global DNA and gene chip (microarray) market by product (consumables and instrumentation), type (oligonucleotide based chips and cDNA chips), application (gene expression, genomics, cancer diagnosis & treatment, environmental control, agricultural biology, microbial genotyping, toxic genomics, and drug discovery), end use (academic & government research institutes, hospitals & diagnostic centers, biotechnology & pharmaceutical companies, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global DNA and gene chip (microarray) market? Q.5 What are the business risks and threats to the global DNA and gene chip (microarray) market? Q.6 What are the emerging trends in this DNA and gene chip (microarray) market and the reasons behind them? Q.7 What are some changing demands of customers in this DNA and gene chip (microarray) market? Q.8 What are the new developments in this DNA and gene chip (microarray) market? Which companies are leading these developments? Q.9 Who are the major players in this DNA and gene chip (microarray) market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this DNA and gene chip (microarray) market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global DNA and gene chip (microarray) market? |
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Product (Consumables and Instrumentation), Type (Oligonucleotide Based Chips and cDNA Chips), Application (Gene Expression, Genomics, Cancer Diagnosis & Treatment, Environmental Control, Agricultural Biology, Microbial Genotyping, Toxic Genomics, and Drug Discovery), and End Use (Academic & Government Research Institutes, Hospitals & Diagnostic Centers, Biotechnology & Pharmaceutical Companies, and Others) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
Methodology
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.